tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Jaguar Health launches Gelclair prescription product in the U.S.

Jaguar Health announced that Jaguar family company Napo Pharmaceuticals has initiated the commercial launch of the FDA-approved oral mucositis prescription product Gelclair in the U.S. Napo’s core target audiences for the Gelclair launch are patients with head and neck cancer and oncology-focused health care practitioners. As part of the ongoing Gelclair launch, Napo plans to exhibit at several key oncology conferences in the coming months, and there will also be a strong digital marketing component to the launch, targeting health care providers and providing information and education for patients to self-advocate.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1